An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia - Concepedia

Concepedia

Publication | Open Access

An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemia

DOI Full Paper Access

61

Citations

60

References

2020

Year

Jeevisha Bajaj, Michael Hamilton, Yutaka Shima, Kendall R. Chambers, Kyle Spinler, Eric L. Van Nostrand, Brian A. Yee, Steven M. Blue, Michael Chen, David Rizzeri,

Key RegulatorMolecular BiologyGene EditingCrisprMyeloid LeukemiaRna-binding Protein Staufen2MedicineCell BiologyGenome EditingMolecular MedicineMyeloid Neoplasia

References

	Year	Citations

Page 1

Page 1